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The success of the use of liposomes as drug carriers depends on both their formulation and the method of
preparation. We have carried out a series of in vitro studies using different formulations and preparation
methods, with the aim of obtaining a type of liposome which is efficient in the treatment of brucellosis. On the
basis of results obtained in studies of stability at 37&C in the presence of serum lipoproteins and of the
activation of phagocytic cells and antibiotic transport to the interior of monocytes infected with Brucella
abortus, we conclude that the most suitable vesicles are positively charged, stable plurilamellar vesicles
(phosphatidylcholine, 30% cholesterol, and 10% stearylamine). Gentamicin incorporated into these cationic
liposomes completely eliminated all of the intracellular Brucella organisms (4.6 logs), while free gentamicin was
capable of reducing the number of intracellular bacteria by only 0.3 log.
Brucellosis is a zoonosis which causes major economic
losses. The intracellular localization of Brucella species makes
treatment difficult, given that most antibiotics which have been
seen to be efficient in vitro do not actively pass through cellular
membranes (16). Hence, it has been proposed to use liposomes
as an effective vehicle for getting antibiotic into Brucella-in-
fected phagocytes. Liposomes are vesicles which are composed
of one or several lipid bilayers which enclose an aqueous
phase, so they are capable of transporting different substances,
with antibiotics being among them. Given that liposomes are
particularly foreign to the body, they are captured by the cells
of the mononuclear phagocytic system, such as blood mono-
cytes and macrophages of the liver, spleen, and bone marrow
(28). This fact, which could be a disadvantage in the treatment
of some infections, can be of great benefit in the treatment of
those which target the mononuclear phagocytic system for ac-
tion, as is the case with brucellosis.
Before they can interact with phagocytic cells, liposomes
have to overcome another obstacle in the bloodstream: struc-
ture destabilization as a result of interaction with certain serum
components. High-density lipoproteins (HDL) seem to be
mainly responsible for this process (7, 29, 31). Although the
mechanism is not clear, it has been suggested that during the
interaction of a lipoprotein and a vesicle, some of the lipids are
transferred from the liposome to the lipoprotein (21, 29, 34),
leaving different-sized pores through which the contents are
released (20).
Therefore, for a liposome to be efficient in the treatment of
brucellosis and other infections which affect the mononuclear
phagocytic system, it should be stable in the bloodstream and
interact efficiently with monocytic-macrophagic cells. In our
study, we examined how these parameters are affected by vari-
ations in both the composition of the liposome and the prep-
aration method of the vesicles. Therefore, we compared a new
liposomal formulation (35) with liposomal formulations used
by other authors for the experimental treatment of brucellosis
(8, 11, 17). The effect of the incorporation of different propor-
tions of cholesterol (CHL) and charged molecules on the sta-
bility of vesicles in the presence of HDL was studied. In addi-
tion, the effects on the degree of interaction with monocytic
cells and on the therapeutic capacity of gentamicin encapsu-
lated in different types of liposomes for monocytes infected
with Brucella abortus were also studied.
(Some of these data were presented at the 6th European
Congress of Clinical Microbiology and Infectious Diseases,
Seville, Spain, in 1993 and at the 13th International Sympo-
sium of the World Association of Veterinary Microbiologists,
Immunologists and Specialists in Infectious Diseases, Perugia,
Italy, in 1994.)
MATERIALS AND METHODS
The following freeze-dried compounds (Sigma Chemical Co.) were used to
prepare the vesicles: egg yolk phosphatidylcholine (PC; 60% pure), CHL (99%
pure), dicetylphosphate (DP; 97% pure), and stearylamine (ST; 99% pure).
Bovine HDL and the fluorochrome 5(6)-carboxyfluorescein (CF; 99% pure)
were also purchased from Sigma. Sephadex G-50 medium was purchased from
Pharmacia-LKB. For the mononuclear phagocytic system studies, the mouse
monocyte J774 cell line (ATCC TIB 67) was used. The culture medium used to
maintain this line was Dulbecco’s modified Eagle medium (DMEM, Whittaker)
supplemented with fetal calf serum (Gibco). Other reactive agents used in this
analysis were of analytic grade.
Preparation of liposomes. (i) Preparation of MLVs. The preparation tech-
nique for multilamellar vesicles (MLVs) described by Dees et al. (8) consisted of
the hydration of the suspension of previously dried lipids (10 mg/ml) in Hanks
balanced salt solution (Sigma Chemical Co.) for 30 min. The emulsion was then
vigorously shaken for 15 min until a homogeneous liposome suspension (multi-
lamellar type) was obtained. The separation of the nonencapsulated material was
done by filtration in a Sephadex G-50 column (15 by 1 cm).
(ii) Preparation of freeze-thaw MLVs. Another type of MLV was prepared by
following the technique described by Herna´ndez-Caselles et al. (17). Phospho-
lipids (PC) and suitable amounts of CHL, ST, and DP were dissolved in chlo-
roform. The solvent was evaporated under nitrogen current, with the final traces
being eliminated by vacuum drying for 3 h. The MLV-type vesicles were pre-
pared by adding the aqueous phase (saline solution, 0.85% NaCl) to the phos-
pholipid film and shaking the suspension vigorously in three heating cycles at
508C and cooling at 48C until a homogeneous suspension was obtained. The
separation of the nonencapsulated material was done by centrifuging the sus-
pension three times at 15,000 3 g (for 15 min each time). The liposomes were
finally suspended again at a concentration of 50 mg of PC per ml in saline
solution.
(iii) Preparation of SPLVs. Stable plurilamellar vesicles (SPLVs) were pre-
pared by following the method described by Fountain et al. (11). The phospho-
lipid suspension was dispersed in a vesicle rotavapor flask with a spherical base
with a volume of 100 ml and was evaporated in a rotavapor at 408C until it dried
completely. Once the suspension had dried, the phospholipids were dissolved in
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10 mg of diethyl ether per ml, and 0.3 ml of the aqueous phase (HEPES
[N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid] buffer [10 mM HEPES,
145 mMNaCl, 0.02% sodium azide [pH 7.4]) was added. The mixture was shaken
for 30 s in a mechanical shaker and then placed in a bath-type sonicator, with a
nitrogen current being passed through it to facilitate evaporation during the
sonication. When no trace of diethyl ether was found to be present, the mass of
SPLVs was dispersed in saline solution with a mechanical shaker. The nonen-
capsulated material was separated by centrifuging the mixture at 15,000 3 g for
10 min. The process was repeated three times, and the SPLVs were finally
suspended in saline solution once more (10 mg of phospholipids per ml).
(iv) Preparation of modified SPLVs. This method was based on that of Foun-
tain et al. (11), with some modifications as described below. First, the suspension
of phospholipids was done in chloroform at 10 mg/ml. After the aqueous phase
was added (HEPES buffer), the liposome emulsion was obtained by vortex
agitation for 30 s and then by sonication in a bath-type sonicator (P-Selecta; 50
W) for 2 min at room temperature. Organic-phase excess was eliminated with a
vacuum rotavapor by applying low pressure (200 to 300 mm of Hg) for 5 min at
a bath temperature of 408C. A nitrogen stream was applied to remove any trace
of solvent. The liposomes were suspended again in the HEPES buffer with the
help of 5-mm-diameter glass beads. The elimination of the nonencapsulated
material was done by column filtration (Sephadex G-50), except in cases of
positively charged vesicles, as these interact with the column. In these cases,
three washes in HEPES buffer were done (15,000 3 g for 15 min).
Determination of CF and gentamicin. (i) Encapsulation percentage of CF. The
fluorescence of each liposome sample was checked before and after being dis-
rupted with 100 ml of Triton X-100 (10%) and then being boiled for 10 min. The
quantity of encapsulated CF was calculated by subtracting the initial fluorescence
value of the liposomes from that of the lysed ones (total fluorescence) and then
extrapolating this value with the linear equation obtained with known concen-
trations of CF. The percentage of encapsulated CF was calculated with respect
to a known concentration of CF included in the aqueous phase during the
preparation of the liposomes (see below).
(ii) Determination of gentamicin. To evaluate the bactericidal capacity of
gentamicin encapsulated in different types of liposomes, a fixed concentration of
gentamicin was used (20 mg/ml; see below). The gentamicin encapsulated in the
liposomes was quantified with o-phthalaldehyde by the method of Benson and
Hare (6). The amine antibiotic reacts with o-phthalaldehyde in the presence of
b-mercaptoethanol at 218C, forming a product which can be detected by fluo-
rescence spectroscopy. The sensitivity of the technique is 1 mg of antibiotic per
ml. Readings were taken with a Cytofluor 2300/2350 (Millipore) fluorimeter,
adjusted to wavelengths of 360 nm for excitation and 460 nm for emission.
Fluorimetric technique for the study of stability and half-life. To study the
stability, half-life, and efficiency of encapsulation of the liposomes, the liposomes
were charged with 50 mM CF in HEPES buffer, pH 7.4 (36). The stability of the
vesicles was studied by continuous follow-up of the increase in fluorescence after
the liposomes (diluted in HEPES buffer, pH 7.4, at 50 mg of lipids per ml) were
incubated in the presence of HDL (173 mg/ml) for 5 min, with an automatic
reading being taken every 0.1 s. The same liposome population suspended in 10
mM HEPES buffer (pH 7.4) was used as a control group to observe the effect of
incubation at 378C. The increase in fluorescence was determined with a Perkin-
Elmer LS-50 spectrofluorimeter (Perkin-Elmer Corp., Norwalk, Conn.). The
reading conditions were as follows: excitation, 490 nm; emission, 538 nm; and slit
width, 10 nm.
The half-life of each liposomal formulation was also studied, i.e., the time
interval needed to liberate 50% of the encapsulated CF in the presence of bovine
HDLs (173 mg/ml) at 378C. For each time course, six points in time were taken
(1, 1.5, 3, 4, 20, and 50 h). In some experiments (see text), the follow-up was
prolonged to 150 h.
In vitro studies. (i) Culture and maintenance of monocytes. The mouse mono-
cytes of the J774 tumor line were kept in sterile and ventilated culture flasks
(Costar). The culture medium used was DMEM supplemented with 10% fetal
calf serum. The cells were transferred to fresh medium every 3 or 4 days and then
were recovered with the aid of a rubber policeman, with the medium being
centrifuged at 200 3 g for 5 min at 48C.
(ii) Activation of monocytes. The Nitro Blue Tetrazolium test (1) was used to
determine the degree of activation of the monocytes following the interaction
with the liposomes. In the presence of radical O22, Nitro Blue Tetrazolium
(soluble and yellow) is reduced to formazan, an insoluble blue-black material
which precipitates intracellularly and can be spectrophotometrically quantified
after extraction of the cells with N,N-dimethylformamide. The technique consists
of placing 2 3 106 monocytes in 0.5 ml of medium plus 0.5 ml of liposomes
diluted 1:5 in 0.2% Nitro Blue Tetrazolium in saline solution in cone-shaped vials
(Eppendorf type). The basal activity of the monocytes was determined by incu-
bating the cells in 0.5 ml of 0.2% Nitro Blue Tetrazolium in saline solution.
Zymosan A (Saccharomyces cerevisiae; Sigma) at a concentration of 60 mg/ml in
saline solution was used as a positive control for activation. The zymosan was
deactivated before use by boiling it for 10 min. Before the activators (zymosan
and the liposomes) were added to the monocytes, it was necessary to opsonize
them with mouse serum (250 ml of the activator was incubated at 378C for 30 min
with 4 ml of serum prediluted to 1/10).
The monocytes were incubated with the opsonized activators for 4 h at 378C;
then they were centrifuged for 3 min at 13,000 3 g, and the purple precipitate
corresponding to the formazan was observed. To extract the precipitate, the
supernatant was incubated with 1 ml of N,N-dimethylformamide at 568C for 18
h. After the supernatant was centrifuged for 3 min at 13,000 3 g, the optical
density of the supernatant at 515 nm was determined.
(iii) Phagocytosis of Brucella abortus and evaluation of the bactericidal capac-
ity of gentamicin encapsulated in liposomes.Monocytes at 106 per cup in 0.5 ml
of culture medium were placed on 24-well plates (Costar). After the cells were
incubated for 1 h at 378C, 100 ml of saline solution containing 106 CFU of B.
abortus 2308 biotype 1 (for a monocyte-to-B. abortus ratio of 1:1) was added. The
bacteria used in this experiment were in their log phase after growth on tryptone-
soy agar plates, and they were opsonized with serum from mice experimentally
infected with B. abortus (900 ml of bacterial suspension was incubated for 30 min
at 378C with 100 ml of serum prediluted 1:1,000). The monocytes were kept in
contact with the opsonized bacteria for 24 h at 378C so that phagocytosis could
take place. Once this period was over, the noningested bacteria were eliminated
by three vigorous washings with DMEM and by centrifuging them in the micro-
plate at 200 3 g for 5 min at 48C. Following this, 0.5 ml of fresh DMEM
supplemented with 10% fetal calf serum per well was added, along with a further
100 ml of free or encapsulated gentamicin in opsonized liposomes at a concen-
tration of 20 mg/ml. All treatments were performed in duplicate. The antibiotics
were allowed to act for 5 h at 378C. The plates were then washed with DMEM
and centrifuged at 200 3 g, and a sample of the last supernatant was taken to
determine the number of extracellular bacteria by culture on tryptone-soy agar
plates. Finally, the monocytes were disrupted in three freeze-thaw cycles. After
culture on tryptone-soy agar plates and incubation for 4 days at 378C, the number
of surviving intracellular bacteria was calculated by estimating the difference
between the number of total bacteria (obtained after disruption of the cells) and
the number of extracellular bacteria.
RESULTS
Stability of the liposomes in the presence of HDL. (i) Effect
of CHL. Liposomes which carried different molar proportions
of PC and CHL (3:1, 2:1, 1:1, 1:2, and 1:0) were studied. The
results in Table 1 show how the incorporation of CHL into the
liposomes significantly increased their resistance to serum
HDL. The continuous fluorimeter readings shown in Fig. 1
illustrate the effect of CHL on the stability of the liposomes.
The amount of CF released increased in proportion with a
longer incubation period with HDL. The half-life of the vesi-
cles could be determined when this effect was followed up to 50
h after incubation. The liposomes with greater longevity were
the $50% CHL-enriched ones (up to 50 h), while those with
33% or less CHL showed a shorter half-life (#4 h) (Table 1).
Furthermore, the incorporation of CHL reduced encapsu-
lation percentages (Table 1). However, although the vesicles
formed of PC alone encapsulated a larger quantity of CF, their
greater instability meant that the quantity of CF transported
after 1.5 h of incubation was higher in those vesicles with CHL
(Fig. 2).
(ii) Effect of the incorporation of a charged molecule. Fol-
lowing the incorporation of a negative charge (DP), the lipo-
somes were more resistant to the action of the serum lipopro-
teins than those formed exclusively of PC and CHL (Table 2).
However, the incorporation of a positive charge (ST) did not
TABLE 1. Effect of liposomal CHL content on the stability and the
percentage of encapsulation of CF in modified SPLVs
Liposome
composition
(ratio)
CF release (%)a Half-life
(h)
Encapsulation
(%)5 min 3 h
PC 45.0 71.6 1–4 13.30
PC-CHL (3:1) 25.6b 58.5b ,1 2.00c
PC-CHL (2:1) 16.7b 47.9b 1–4 3.83c
PC-CHL (1:1) 3.7c 28.5b 4–20b 2.42c
PC-CHL (1:2) 0.0d 16.3c 20–50c 8.80b
a The percentage of CF release was determined after incubation of the lipo-
somes in 173 mg of HDL per ml at 378C.
b P , 0.05 for difference from the PC liposomes by Student’s t test.
c P , 0.01 for difference from the PC liposomes by Student’s t test.
d P , 0.001 for difference from the PC liposomes by Student’s t test.
VOL. 40, 1996 OPTIMIZATION OF LIPOSOMES AS DRUG CARRIERS 147
change the half-life of the liposomes with respect to those
formed of PC and CHL. Moreover, the encapsulation percent-
ages were not affected when the vesicles carried a positive or
negative charge (Table 2).
(iii) Comparison with other liposome formulations. To carry
out the comparative study, we prepared liposomes with the
same compositions by following different methods. The anal-
ysis revealed that the stabilities of the different types of vesicles
were similar, although in the first hours of incubation, the
modified SPLVs were generally more unstable (Table 3). Nev-
ertheless, the encapsulation percentages achieved by the meth-
ods of Dees et al. (MLVs) (8), Herna´ndez-Caselles et al.
(freeze-thaw MLVs) (17), and Fountain et al. (SPLVs) (11)
were significantly lower than those obtained by the modified
SPLV method described before. In a experiment followed out
to 20 h with liposomes prepared by different methods and
exposed to HDL at 378C, we found that with the exception of
vesicles formed exclusively of PC, the amount of CF trans-
ported by the modified SPLVs was greater than that trans-
ported by vesicles formed by the other methods (results not
shown).
Activation of monocytes with liposomes with different for-
mulations. After studying the level of formazan production
(correlated with the O2
2 yield; see Materials and Methods) in
the monocytes of the J774 tumor line, we observed three ef-
fects. First, the method of preparation influenced the degree of
activation of the monocytic cells. Table 4 shows that empty
vesicles that had the same composition (PC) but that were
prepared by different methods (MLVs [8], SPLVs [11], and
modified SPLVs) produced different levels of formazan. The
modified SPLV liposomes appeared to be more efficient than
comparable SPLV andMLV liposomes in activating the mono-
cytes, as was indicated by the higher optical density for the
modified SPLVs (Table 4). Second, we observed an inhibitory
effect of CHL. Vesicles prepared by the modified SPLV
method with increasingly higher CHL concentrations (0, 25,
30, and 50%) showed decreasing levels of activation (Table 4).
Finally, we also observed an inhibitory effect of the negative
charge, while positively charged liposomes gave activation val-
ues similar to those of the zymosan positive control group
(Table 4).
Effect of gentamicin encapsulated in liposomes on mono-
cytes infected with B. abortus. To evaluate the bactericidal
capacity of gentamicin encapsulated in liposomes, we used the
J774 monocytes experimentally infected with B. abortus. These
cells were then treated with free gentamicin or gentamicin
encapsulated in different types of liposomes. The results (Ta-
ble 5) showed that the free gentamicin was capable of reducing
the number of intracellular bacteria by only 0.3 log in terms of
the infected and untreated control group. On the other hand,
enhanced gentamicin activity was detected when it was encap-
sulated in some types of liposomes. Liposomes with a net
positive charge were generally the most efficient, regardless of
the method used for their preparation. The positively charged
MLV liposomes (MLVs 1) and freeze-thaw MLVs 1 led to
reductions of 0.59 and 1.58 logs of Brucella organisms, respec-
tively, compared with the untreated control group. The posi-
tively charged modified SPLVs with 30% CHL completely
eliminated all the intracellular B. abortus, with a 4.58-log re-
duction relative to the untreated control group and a 4.13-log
reduction compared with the group treated with free gentami-
cin. The statistical analysis (Student’s t test) revealed signifi-
cant differences between the untreated control group and the
one treated with free gentamicin (P , 0.001). Significant dif-
ferences were also observed (P , 0.01) for the treatments with
FIG. 1. Effect of liposomal CHL content on the relative release of CF from
modified SPLV liposomes. Relative fluorescence (RFU) as a function of the time
of incubation in HDL (173 mg/ml) at 378C is shown graphically.
FIG. 2. Effect of liposomal CHL content on the amount of CF carried by
modified SPLV liposomes. Relative fluorescence (RFU) as a function of the time
(Tiempo) of incubation in HDL (173 mg/ml) at 378C is shown graphically. E, PC
alone; F, PC-to-CHL ratio of 3:1; h, PC-to-CHL ratio of 2:1; n, PC-to-CHL
ratio of 1:1; , PC-to-CHL ratio of 1:2.
TABLE 2. Effect of the inclusion of a charged molecule
(DP or ST) on the stability and the percentage of
encapsulation of CF in the modified SPLVs
Liposome composition
(ratio)
CF release
(%)a Half-life
(h)
Encapsulation
(%)5
min 3 h
PC-CHL (1:1) 3.7 28.5 4–20 2.42
PC-CHL-DP (4:5:1) 0.0b 12.0b .150c 2.17
PC-CHL-DP (7:8:1) 0.0b 7.5b 50–150c NDd
PC-CHL-ST (4.5:5:0.5) 5.5 24.3 4–20 2.12
a The percentage of CF release was determined after incubation of the lipo-
somes in 173 mg of HDL per ml at 378C.
b P , 0.05 for difference from the neutral liposomes by Student’s t test.
c P , 0.01 for difference from the neutral liposomes by Student’s t test.
d ND, not determined.
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positively charged MLV and SPLV liposomes. The viability
studies (exclusion of trypan blue) indicated that the proportion
of ST used is not toxic for the cells, as viability levels of more
than 93% were obtained (the viability of the untreated control
group was more than 95%). The incorporation of CHL also
reduced the levels of interaction between liposomes and mono-
cytes. Thus, the reduction in the number of B. abortus was
greater with the positively charged vesicles with 30% CHL than
with the same vesicles with 50% CHL (logarithmic reduction
of 4.58 as opposed to 0.84).
DISCUSSION
New methodologies have been developed in recent years to
optimize liposomes as the transport system for active princi-
ples. In this study, our aim was to obtain a suitable type of
liposome for transporting drugs into phagocytic cells infected
with B. abortus. We have therefore focused on permeability
control, liposome half-life, and the in vitro interaction with
monocytes.
Given the characteristics of SPLVs (multilamellarity, high
encapsulation efficiency, and greater stability), we opted for
the encapsulation of antibiotics in this kind of liposome. How-
ever, we introduced two changes to the classic preparation
methods of Gruner et al. (14) and Fountain et al. (11). First, as
a solvent, we used chloroform instead of diethyl ether, because
of the higher solubility of some components, such as DP and
ST, in chloroform. Second, a vacuum rotovapor was used to
evaporate organic-phase excess at a controlled temperature
(408C) and pressure (200 to 300 mm of Hg). We thus ensured
the homogeneity of the different liposomal preparations and
promoted their drying in a fine and extensive layer on the
surface of the flask by using low pressure and a rotating move-
ment, thereby achieving the total elimination of the organic
phase. The evaporation of the liposomes by using low pressure
is recommended to avoid vesicle deterioration (5).
Once the method of liposome preparation was established,
we studied the stability of the liposomes in vitro. We used a
fluorimeter method based on the release of encapsulated CF to
gauge liposomal stability. This method, introduced by Wein-
stein et al. (36) and applied by Szoka et al. (33), is based on the
principle that CF fluoresces strongly when its concentration is
low, so a critical quantity of CF that does not fluoresce (self-
quenching) when it is encapsulated in the liposome but does
fluoresce when it is released was used. Moreover, stability
studies were done at 378C in the presence of serum compo-
nents, given that the instability of liposomes in the bloodstream
is a well-known phenomenon; in most studies in which encap-
sulated antibiotics are used in liposomes with a therapeutic
aim, they are introduced intravenously (2). The stability of the
liposomes in the presence of serum proteins may be enhanced
by changes in the composition of the vesicles. Therefore, we
studied the effect of the incorporation of CHL and a charged
molecule on the stability and half-life of the vesicles.
The results showed that the incorporation of CHL led to a
significant increase in the resistance of the liposomes to the
serum lipoproteins. These results agree with predictions and
with the results of other authors (4, 9, 13, 15, 20, 25). In
addition to the effect on stability, another consideration is the
effect of CHL on encapsulation performance. Our results in-
dicate that this performance is diminished following the incor-
poration of CHL. This drop could be related to the fact that
CHL can modify the thickness of the lipid bilayer after it enters
the lipid membrane (23). Nevertheless, although the CHL-
stabilized liposomes showed lower encapsulating efficiency,
their greater stability in the presence of HDL meant that the
amount of CF transported was higher than that transported by
vesicles formed exclusively of PC.
The incorporation of a negative charge made the liposomes
more resistant to the action of the serum lipoproteins, while
the incorporation of a positive charge did not improve the
stability of the vesicles which had previously been stabilized
with CHL. These results coincide with those described by
TABLE 3. Effect of the method of liposome preparation on the relative stability and percentage of encapsulation of CF
Liposome Composition (ratio)
CF release (%)a
Half-life (h) Encapsulation (%)
5 min 3 h
Modified SPLV PC 36.0 71.6 1.0–4.0 13.3
MLV PC 3.9b 70.9 1.0–1.5 0.7c
SPLV PC 8.1c 18.6b 1.5–4.0b 9.2b
Modified SPLV PC-DP (7:2) 25.3 72.0 1.5–4.0 2.4
MLV PC-DP (7:2) 0.0c 22.9c 1.5–4.0b 0.6b
Modified SPLV PC-CHL-DP (5:1:0.5) 0.0 14.1 20–50 6.9
Freeze-thaw MLV PC-CHL-DP (5:1:0.5) 0.0 8.2 20–50 2.6b
Freeze-thaw MLV PC-CHL-ST (5:1:0.5) 0.0 10.4 20–50 3.7b
a The percentage of CF release was determined after incubation of the liposomes in 173 mg of HDL per ml at 378C.
b P , 0.05 for difference from the modified SPLV liposomes by Student’s t test.
c P , 0.01 for difference from the modified SPLV liposomes by Student’s t test.
TABLE 4. Activation of monocytes with liposomes and
determination of O2
2 production
Liposomea Composition (ratio) OD515b
Modified SPLV PC 1.060c
Modified SPLV PC-CHL (3:1) 1.050c
Modified SPLV PC-CHL (2:1) 0.883
Modified SPLV PC-CHL (1:1) 0.621
Modified SPLV 2 PC-CHL-DP (6:3:1) 0.400c
Modified SPLV 1 PC-CHL-ST (6:3:1) 0.696
SPLV PC 0.502c
MLV PC 0.302c
MLV 2 PC-DP (7:2) 0.376c
MLV 1 PC-ST (7:2) 0.155c
Freeze-thaw MLV 2 PC-CHL-DP (5:1:0.5) 0.272c
Freeze-thaw MLV 1 PC-CHL-ST (5:1:0.5) 0.781
Freeze-thaw MLV 1 PC-CHL-ST (6:3:1) 0.312c
Freeze-thaw MLV 1 PC-CHL-ST (7:3:0.5) 0.374c
Zymosan 0.792
a 2, negative charge; 1, positive charge; Zymosan, activation control.
b OD515, optical density of formazan at 515 nm. Formazan was the product
from the reaction with O22 from the monocyte.
c P , 0.05 for difference from the control (Zymosan) by Student’s t test.
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Allen and Cleland (4). While these authors do not explain the
causes of these effects, these effects could be due to the union
of some serum proteins, depending on the charge and lipid
composition of the liposome (19).
Comparative studies of the stabilities of vesicles prepared by
different techniques indicate that in addition to the composi-
tion of the liposomes, the method of preparation also has an
influence on the physical and chemical characteristics of the
vesicles, thus affecting their stability and encapsulating effi-
ciency. These studies showed that the best vesicles for antibi-
otic transport were modified SPLVs stabilized with CHL.
As was mentioned previously, an effective liposome for the
treatment of brucellosis, assuming sufficient encapsulation ca-
pacity, half-life and stability in the bloodstream, should inter-
act efficiently with the monocytic-macrophagic cells where Bru-
cella organisms are present. The elimination of the liposomes
by monocytic-macrophagic cells takes place in two stages: op-
sonization by serum proteins (immunoglobulins, complement
factors, fibronectin, etc.) followed by the phagocytosis of these
marked liposomes. During these stages, the cells are activated
and release different products. Therefore, in order to measure
the capacity of the liposome to interact with these cells, we
performed an in vitro study of incubation of monocytes with
liposomes, quantifying one of the products of this activation,
the O2
2 anion.
The results demonstrated that lower activation values are
obtained as the CHL concentration increases. We also ob-
served a lower therapeutic effect of gentamicin when it was
encapsulated in liposomes with a high CHL content. These
results confirm those of other authors, according to whom an
increase in the proportion of CHL leads to a reduction in
macrophage capture because of the increased rigidity of the
vesicle (3, 26, 27). Moghimi and Patel (24) suggested that after
the incorporation of CHL into the vesicles, the distribution of
phospholipids in the membrane may be changed, making the
union of opsonines and, by extension, the later capture of the
vesicles by cells in the monocytic-macrophagic system more
difficult. Therefore, despite the fact that concentrations of
CHL of 50% or more give greater stability to the liposome in
the presence of HDL, we opted for a concentration of 30%,
which gives excellent stability without compromising the ability
to be captured by the phagocytic cells.
Another factor which plays a major role in the interaction of
the liposomes with the monocytic-macrophagic cells is the sur-
face charge. There is strong controversy on this matter. Some
authors state that negative charges favor the interaction and
later capture (10, 12, 18) and that positive charges do not favor
these events (32). On the other hand, others believe that it is
precisely the positively charged liposomes which interact better
with the cells (17, 22, 30). Our results support the latter posi-
tion, as the positively charged liposomes led to a greater acti-
vation of the monocytes than liposomes with negative charges.
Moreover, the positively charged liposomes (regardless of the
method of preparation) produced a greater reduction of the
infection compared with the untreated monocytes. These re-
sults suggest that there is some mechanism which favors the
interaction of the positively charged liposomes and the mono-
cytic-macrophagic cells, thus promoting the transport of anti-
biotic to these cells. This observation is consistent with the
hypothesis of Magee et al. (22) that positively charged lipo-
somes interact with the negatively charged cells by electrostatic
adsorption and are then internalized by fusion or endocytosis.
The different observations by various authors could be ac-
counted for by differences in the methods of preparation, phos-
pholipids, and the cellular line used for the studies of interac-
tion and capture of liposomes.
Our results also suggest that the preparation method may
affect liposome capture, as we have observed differences
among liposomes with the same compositions but which were
prepared by different methods. Thus, the activation values
obtained with PC vesicles of the modified SPLV type were
higher than those obtained with vesicles prepared according to
the methods of Dees et al. (MLV) (8), Fountain et al. (SPLV)
(11), and Herna´ndez-Caselles et al. (freeze-thaw MLV) (17).
Regardless of differences in size, heterogeneity, and/or mor-
phology (including lamellarity) for vesicles prepared by differ-
TABLE 5. Enhanced intraphagocytic killing of B. abortus in murine monocytes by liposomes containing gentamicin
Treatmenta Liposome Composition (ratio) Reduction ofinfection (log)
Untreated controlb 0.00
Free gentamicin 0.34
Gentamicin-containing liposome
MLV PC 0.24
MLV 2 PC-DP (7:2) 0.04
MLV 1 PC-ST (7:2) 0.59
SPLV PC 0.08
Freeze-thaw MLV 2 PC-CHL-DP (5:1:0.5) 0.50
Freeze-thaw MLV 1 PC-CHL-ST (5:1:0.5) 1.58c
Modified SPLV PC 1.00d
Modified SPLV PC-CHL (3:1) 0.20
Modified SPLV PC-CHL (2:1) 0.23
Modified SPLV PC-CHL (1:1) 0.00
Modified SPLV 2 PC-CHL-DP (4:5:1) 0.30
Modified SPLV 2 PC-CHL-DP (6:3:1) 0.13
Modified SPLV 1 PC-CHL-ST (4:5:1) 0.84d
Modified SPLV 1 PC-CHL-ST (6:3:1) 4.58e
Modified SPLV 1f PC-CHL-ST (6:3:1) 0.00
a Gentamicin was used at 20 mg/ml.
b The level of infection in the untreated monocytes was 3.8 3 104 CFU.
c P , 0.01 for difference from the free gentamicin-treated group by Student’s t test.
d P , 0.05 for difference from the free gentamicin-treated group by Student’s t test.
e P , 0.001 for difference from the free gentamicin-treated group by Student’s t test.
f These liposomes were empty.
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ent methods, the differences could be due to the effect of
liposomal fluidity on capture (3, 26, 27). Furthermore, and
contrary to results reported by other authors, when we used the
formulations and methods of preparation of other authors, we
obtained very low levels of reduction of infection (8, 11). This
disagreement may be due to differences in the cellular line
used and the experimental conditions (incubation times, cul-
ture media, etc.).
In summary, it is possible to improve the degree of interac-
tion and capture of liposomes by phagocytic cells by using a
suitable liposome design. In this study, we have observed that
the best results in terms of stability, activation of monocytes,
and efficient antibiotic transport were achieved with modified
SPLVs stabilized with 30% CHL and positively charged. These
liposomes also demonstrated good efficiency as transport ve-
hicles of antigenic extracts of Brucella melitensis, producing a
protective effect against experimental murine brucellosis (35).
Studies on the treatment of experimentally infected animals
with gentamicin encapsulated in this type of liposome are now
in progress.
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